The fate of Dylann Roof will likely wind through thickets of legal appeals and an equally onerous state trial before it is ultimately resolved.
Its provisions are so onerous (the trial court found that building or buying an A.S.C. would cost an abortion provider millions of dollars) that all but nine or ten of the forty-one abortion providers that operated in Texas before H.B. 2 passed, in 2013, have been forced to close.
Likewise pharmaceuticals companies find the requirements on transparency around clinical trials onerous and should be allowed longer patents – that is, more expensive drugs for the rest of us.
Second, they could delay the launch of a highly innovative drug by demanding onerous or unnecessary trials and thereby deny many needy patients a new therapy.Proper regulation requires balancing these two risks, but the pitch may be queered by bureaucratic self-interest.
As a result of Frosh's decision, District Court Chief Judge John P. Morrissey advised judges and commissioners in October to impose the "least onerous" conditions on those awaiting trial.
In the meantime, District Court Chief Judge John P. Morrissey advised judges and commissioners to impose the "least onerous" conditions on those awaiting trial, and Frosh asked the Court of Appeals to consider a rule change.
Trial investigators managed complete capture of the mortality outcome in the long term trials, and took onerous steps to ascertain the vital status of all randomised patients, even if they had discontinued treatment, thus minimising the risk of bias from differential follow-up and selective outcome reporting.
But research is being hampered by resistance from activists and discouraged by governmental over-regulation - including by the FAO agency that sets international food standards, and by onerous, unscientific regulation of field trials under the UN's Cartagena Protocol (which was created under the auspices of the CBD).
In his concluding remarks, Lee noted that the duration of the Apple-Samsung trial highlights the often onerous path to resolution in the U.S. judicial system.
Biomarkers could also provide a more nuanced and timely description of the progression and activity of the disease, and would be less expensive and less onerous for patients and participants in trials.
This was something that had been both feasible and acceptable for the six months of the pilot study, but proved overly time-consuming and onerous for many participants in the full trial, with the response rate being quite poor after the first 3 months.
